Dr. Peng Zhihai (彭志海) - Director of Hepatobiliary and Pancreatic Surgery at Shanghai General Hospital

Dr. Peng Zhihai (彭志海) - Director of Hepatobiliary and Pancreatic Surgery at Shanghai General Hospital

Introduction

Dr. Peng Zhihai (彭志海) is the Director of the Department of Hepatobiliary and Pancreatic Surgery at Shanghai General Hospital (Shanghai First People's Hospital), affiliated with Shanghai Jiao Tong University School of Medicine. One of China's most respected hepatobiliary and pancreatic surgeons, Dr. Peng brings over 20 years of specialized experience in the surgical treatment of liver, biliary tract, and pancreatic diseases. He is internationally recognized for his expertise in minimally invasive hepatobiliary surgery, liver cancer resection, and complex pancreatic procedures. His commitment to surgical innovation and multidisciplinary oncologic care has made Shanghai General Hospital a leading destination for patients with complex hepatobiliary and pancreatic conditions, including international patients seeking world-class care in Shanghai.

Academic Distinctions & Leadership

  • Director, Department of Hepatobiliary and Pancreatic Surgery, Shanghai General Hospital
  • Professor of Surgery, Shanghai Jiao Tong University School of Medicine
  • Chief Physician, Shanghai General Hospital (Shanghai First People's Hospital)
  • Vice Chairman, Hepatobiliary Surgery Branch, Shanghai Medical Association
  • Member, Chinese Society of Surgery, Hepatobiliary Surgery Branch
  • Member, Chinese Anti-Cancer Association, Liver Cancer Committee
  • Member, International Hepato-Pancreato-Biliary Association (IHPBA)
  • Editorial Board Member, multiple leading hepatobiliary surgery journals
  • Recipient, Shanghai Science and Technology Award
  • Recipient, Shanghai Medical Science and Technology Award

Specializations & Expertise

Liver Cancer Surgery

  • Anatomic liver resection for hepatocellular carcinoma (HCC)
  • Major hepatectomy (hemihepatectomy, trisectionectomy)
  • Laparoscopic and robotic liver resection
  • Repeat hepatectomy for recurrent liver cancer
  • Liver resection combined with vascular reconstruction
  • Two-stage hepatectomy with portal vein embolization (PVE)
  • Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)
  • Liver resection for colorectal liver metastases
  • Liver resection for intrahepatic cholangiocarcinoma

Biliary Tract Surgery

  • Hilar cholangiocarcinoma (Klatskin tumor) resection
  • Distal cholangiocarcinoma resection
  • Gallbladder cancer surgery
  • Complex bile duct reconstruction
  • Biliary stricture repair
  • Choledochal cyst excision
  • Laparoscopic cholecystectomy for complex cases

Pancreatic Surgery

  • Pancreaticoduodenectomy (Whipple procedure)
  • Distal pancreatectomy with or without splenectomy
  • Total pancreatectomy
  • Minimally invasive pancreatectomy (laparoscopic and robotic)
  • Pancreatic cyst resection
  • Surgery for pancreatic neuroendocrine tumors (PNETs)
  • Chronic pancreatitis surgery (Frey procedure, Beger procedure)

Minimally Invasive Hepatobiliary Surgery

  • Laparoscopic major hepatectomy
  • Robotic-assisted liver and pancreatic surgery
  • Laparoscopic bile duct exploration and reconstruction
  • Minimally invasive resection of liver tumors in difficult locations
  • Single-incision laparoscopic surgery

Interventional & Ablative Therapies

  • Radiofrequency ablation (RFA) for liver tumors
  • Microwave ablation (MWA) for liver tumors
  • Transarterial chemoembolization (TACE) coordination
  • Hepatic arterial infusion chemotherapy (HAIC) coordination
  • Combination surgery and ablation for multifocal liver cancer

Clinical Excellence & Innovation

Dr. Peng has performed thousands of hepatobiliary and pancreatic surgeries throughout his distinguished career, with a particular reputation for tackling complex cases that other centers may decline. His R0 resection rates and perioperative outcomes consistently meet or exceed national and international benchmarks.

Dr. Peng has introduced and championed several innovative approaches at Shanghai General Hospital:

  • Anatomic Liver Resection: Standardized segment-oriented anatomic resection techniques to maximize oncologic clearance while preserving liver function
  • ALPPS Procedure: One of China's early adopters of ALPPS, enabling resection of previously unresectable liver tumors by rapidly inducing liver hypertrophy
  • Robotic Hepatobiliary Surgery: Established a comprehensive robotic surgery program for liver, bile duct, and pancreatic procedures
  • Precision Hepatectomy: Integrated 3D imaging, intraoperative ultrasound, and fluorescence-guided surgery for precise tumor localization and margin assessment
  • Multidisciplinary Oncology: Built a comprehensive tumor board integrating surgery, interventional radiology, medical oncology, and radiation oncology for optimal treatment planning
  • ERAS Protocols: Implemented enhanced recovery after surgery protocols that reduce hospital stay and improve patient outcomes

Research & Academic Contributions

Dr. Peng is an active researcher with numerous peer-reviewed publications in leading Chinese and international hepatobiliary surgery and oncology journals. His research focuses on:

  • Surgical techniques for complex liver resection
  • Minimally invasive approaches in hepatobiliary surgery
  • Oncologic outcomes of liver cancer surgery
  • Liver regeneration and future liver remnant optimization
  • Perioperative management and ERAS in hepatobiliary surgery
  • Biomarkers for liver cancer prognosis and recurrence

He has participated in multiple national research programs and clinical trials, and regularly presents his work at major national and international hepatobiliary surgery conferences including the International Hepato-Pancreato-Biliary Association (IHPBA) World Congress and the Chinese Society of Surgery Annual Meeting.

Training & Education

As a professor at Shanghai Jiao Tong University School of Medicine, Dr. Peng is committed to training the next generation of hepatobiliary surgeons. He supervises graduate students and residents, and his department serves as a training base for hepatobiliary surgery fellows from across China.

His trainees receive comprehensive exposure to the full spectrum of hepatobiliary and pancreatic surgery, including advanced minimally invasive techniques, complex open surgery, and multidisciplinary oncologic management.

Hospital Affiliation

Shanghai General Hospital (Shanghai First People's Hospital)
Affiliated with Shanghai Jiao Tong University School of Medicine
100 Haining Road, Hongkou District, Shanghai 200080

Shanghai General Hospital is one of Shanghai's premier tertiary academic medical centers, with a long history of clinical excellence and innovation. The Department of Hepatobiliary and Pancreatic Surgery features:

  • Dedicated hepatobiliary and pancreatic surgery operating rooms with advanced laparoscopic and robotic systems
  • Specialized surgical ICU with experienced intensivists
  • Comprehensive pre-operative evaluation and staging facilities
  • Advanced imaging (MRI with liver-specific contrast, CT, PET-CT, intraoperative ultrasound)
  • Multidisciplinary hepatobiliary tumor board with weekly case conferences
  • Integrated interventional radiology suite for TACE, RFA, and biliary interventions
  • Dedicated liver cancer and pancreatic cancer clinics
  • Nutritional support and rehabilitation services
  • International patient services with English-speaking coordinators

Patient Care Philosophy

  • Patient-Centered Care: Every surgical plan is individualized based on tumor characteristics, liver function, and patient goals
  • Multidisciplinary Collaboration: Complex cases reviewed by a dedicated tumor board of hepatobiliary surgeons, oncologists, radiologists, and interventional specialists
  • Evidence-Based Practice: Treatment decisions guided by the latest international guidelines and research
  • Oncologic Radicality: Committed to achieving R0 resection while preserving maximum liver function and quality of life
  • Minimally Invasive When Appropriate: Laparoscopic and robotic approaches used whenever oncologically and technically feasible
  • Comprehensive Support: Addresses medical, nutritional, and psychological needs throughout the surgical journey
  • Transparent Communication: Clear, honest communication about diagnosis, surgical risks, and expected outcomes
  • Long-term Partnership: Committed to ongoing surveillance and support after surgery

Why Choose Dr. Peng Zhihai?

  • Broad Hepatobiliary Expertise: Comprehensive mastery of liver, bile duct, and pancreatic surgery in a single specialist
  • Complex Case Experience: Extensive experience with cases declined elsewhere, including ALPPS, vascular reconstruction, and repeat hepatectomy
  • Minimally Invasive Leadership: One of Shanghai's leading laparoscopic and robotic hepatobiliary surgeons
  • Multidisciplinary Approach: Integrated tumor board ensures every patient receives the optimal combination of surgery, ablation, and systemic therapy
  • Academic Medical Center: Access to the full resources of a major Shanghai Jiao Tong University-affiliated hospital
  • Precision Surgery: Uses 3D imaging, fluorescence guidance, and intraoperative ultrasound for optimal outcomes
  • Cost-Effective Excellence: Hepatobiliary surgery costs in Shanghai are typically 60-75% lower than in the US or Europe
  • International Patient Experience: Experienced in coordinating care for patients from overseas

Conditions Treated

Liver Conditions

  • Hepatocellular carcinoma (HCC / liver cancer) — resectable and borderline resectable
  • Intrahepatic cholangiocarcinoma
  • Colorectal liver metastases
  • Other liver metastases (gastric, neuroendocrine, etc.)
  • Hepatic hemangioma (large or symptomatic)
  • Focal nodular hyperplasia (FNH)
  • Hepatic adenoma
  • Liver abscess (complex or refractory)
  • Hydatid cyst of the liver
  • Polycystic liver disease

Biliary Tract Conditions

  • Hilar cholangiocarcinoma (Klatskin tumor)
  • Distal cholangiocarcinoma
  • Gallbladder carcinoma
  • Choledochal cyst
  • Bile duct stricture (benign and malignant)
  • Recurrent pyogenic cholangitis
  • Complex choledocholithiasis

Pancreatic Conditions

  • Pancreatic ductal adenocarcinoma (PDAC)
  • Pancreatic neuroendocrine tumors (PNETs)
  • Intraductal papillary mucinous neoplasm (IPMN)
  • Mucinous cystic neoplasm (MCN)
  • Solid pseudopapillary neoplasm (SPN)
  • Chronic pancreatitis with complications
  • Pancreatic trauma

International Patient Services

China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking hepatobiliary and pancreatic surgery with Dr. Peng Zhihai at Shanghai General Hospital.

Pre-Treatment Support

  • Medical Record Review: Our team works with Shanghai General Hospital to review your imaging, pathology, and lab results to assess surgical options
  • Virtual Consultation: Arrange a video consultation with Dr. Peng's team to discuss your case and treatment plan
  • Pre-operative Staging Workup: Coordination of comprehensive imaging and functional assessment (liver function tests, volumetry, etc.)
  • Tumor Board Presentation: Your case can be presented at the multidisciplinary hepatobiliary tumor board
  • Second Opinion: Expert second opinion on resectability and optimal surgical strategy
  • Cost Transparency: Detailed cost estimate including evaluation, surgery, hospitalization, and follow-up
  • Visa Assistance: Guidance on obtaining medical visa and invitation letters
  • Accommodation: Help finding suitable housing near Shanghai General Hospital for patient and family

During Treatment

  • Professional Medical Interpretation: Experienced interpreters for all medical interactions
  • Hospital Admission Support: Assistance with registration, payment, and navigation
  • Family Support: Accommodation and support for accompanying family members
  • Surgical Coordination: Communication with family during surgery
  • ICU & Ward Support: Daily updates and interpretation during hospital stay
  • Post-operative Care: Comprehensive support during recovery
  • Medication Management: Assistance with post-operative medications
  • 24/7 Emergency Support: Round-the-clock assistance throughout your stay

Post-Treatment Care

  • Discharge Planning: Coordination of post-discharge care and monitoring
  • Medical Report Translation: Complete translation of surgical reports, pathology, and discharge summaries
  • Adjuvant Therapy Coordination: Assistance with arranging adjuvant chemotherapy, targeted therapy, or TACE if recommended
  • Follow-up Coordination: Arrange post-operative clinic visits and imaging surveillance
  • Long-term Monitoring Plan: Clear guidance on ongoing surveillance schedule
  • Complication Management: Support for any post-operative complications
  • Telemedicine Follow-up: Virtual consultations for ongoing care after returning home
  • Coordination with Home Physicians: Communication with your local oncologist or surgeon

Schedule Your Consultation

If you or a loved one has been diagnosed with liver cancer, a biliary tract tumor, or a pancreatic condition requiring surgery, Dr. Peng Zhihai at Shanghai General Hospital offers comprehensive hepatobiliary and pancreatic surgical expertise with outcomes that rival the best centers globally, at a fraction of Western costs.

Contact China Medical Concierge - Shanghai today to:

  • Request a medical record review to assess surgical options
  • Schedule a virtual consultation with Dr. Peng's surgical team
  • Have your case presented at the multidisciplinary hepatobiliary tumor board
  • Receive a detailed treatment plan and cost estimate
  • Start your journey toward expert hepatobiliary and pancreatic surgery in Shanghai

Bridging international patients with Shanghai's finest hepatobiliary surgeons — because complex surgery deserves the most experienced hands.

댓글 0개

댓글 남기기